English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
  Targeting the Main Protease (Mpro, nsp5) by Growth of Fragment Scaffolds Exploiting Structure-Based Methodologies

Altincekic, N., Jores, N., Löhr, F., Richter, C., Ehrhardt, C., Blommers, M. J. J., et al. (2024). Targeting the Main Protease (Mpro, nsp5) by Growth of Fragment Scaffolds Exploiting Structure-Based Methodologies. ACS Chemical Biology. doi:10.1021/acschembio.3c00720.

Item is

Files

show Files
hide Files
:
altincekic-et-al-2024-targeting-the-main-protease-(mpro-nsp5)-by-growth-of-fragment-scaffolds-exploiting-structure.pdf (Any fulltext), 8MB
Name:
altincekic-et-al-2024-targeting-the-main-protease-(mpro-nsp5)-by-growth-of-fragment-scaffolds-exploiting-structure.pdf
Description:
-
OA-Status:
Not specified
Visibility:
Public
MIME-Type / Checksum:
application/pdf / [MD5]
Technical Metadata:
Copyright Date:
-
Copyright Info:
-
License:
-

Locators

show

Creators

show
hide
 Creators:
Altincekic, Nadide1, 2, Author
Jores, Nathalie1, 2, Author
Löhr, Frank2, 3, Author
Richter, Christian1, 2, Author
Ehrhardt, Claus4, Author
Blommers, Marcel J. J.5, Author
Berg, Hannes1, 2, Author
Öztürk, Sare1, Author
Gande, Santosh L.1, 2, Author
Linhard, Verena1, 2, Author
Orts, Julien6, Author
Abi Saad, Marie Jose6, Author
Bütikofer, Matthias7, Author
Kaderli, Janina7, Author
Karlsson, B. Göran8, 9, Author
Brath, Ulrika8, Author
Hedenström, Mattias10, Author
Gröbner, Gerhard10, Author
Sauer, Uwe H.11, Author
Perrakis, Anastassis12, Author
Langer, Julian D.13, Author                 Banci, Lucia14, 15, AuthorCantini, Francesca14, 15, AuthorFragai, Marco14, 15, AuthorGrifagni, Deborah14, AuthorBarthel, Tatjana16, AuthorWollenhaupt, Jan16, AuthorWeiss, Manfred S.16, AuthorRobertson, Angus17, AuthorBax, Adriaan17, AuthorSreeramulu, Sridhar1, 2, AuthorSchwalbe, Harald1, 2, Author more..
Affiliations:
1Institute for Organic Chemistry and Chemical Biology, Goethe University Frankfurt am Main, Frankfurt, Germany, ou_persistent22              
2Center of Biomolecular Magnetic Resonance (BMRZ), Goethe University Frankfurt am Main, Frankfurt, Germany, ou_persistent22              
3Institute of Biophysical Chemistry, Goethe University Frankfurt am Main, Frankfurt, Germany, ou_persistent22              
4Department of Biochemistry, University of Zurich, Zurich, Switzerland, ou_persistent22              
5SavernaTherapeutics, Biel-Benken, Switzerland, ou_persistent22              
6Department of Pharmaceutical Sciences, University of Vienna, Josef-Holaubek-Platz, Vienna, Austria, ou_persistent22              
7Swiss Federal Institute of Technology, Laboratory of Physical Chemistry, ETH Zurich, Zürich, Switzerland, ou_persistent22              
8Swedish NMR Centre, Department of Chemistry and Molecular Biology, University of Gothenburg, Göteborg, Sweden, ou_persistent22              
9SciLifeLab, University of Gothenburg, Göteborg, Sweden, ou_persistent22              
10Swedish NMR Centre, Department of Chemistry, University of Umeå, Umeå, Sweden, ou_persistent22              
11Protein Production Sweden, Department of Chemistry, University of Umeå, Umeå, Sweden, ou_persistent22              
12Oncode Institute and Division of Biochemistry, The Netherlands Cancer Institute, Amsterdam, The Netherlands, ou_persistent22              
13Proteomics and Mass Spectrometry, Max Planck Institute of Biophysics, Max Planck Society, ou_3262216              
14Magnetic Resonance Center and Department of Chemistry, University of Florence, Sesto Fiorentino, Italy, ou_persistent22              
15Consorzio Interuniversitario Risonanze Magnetiche Metalloproteine, Sesto Fiorentino, Italy, ou_persistent22              
16Macromolecular Crystallography, Helmholtz-Zentrum Berlin, Berlin, Germany, ou_persistent22              
17NIH, LCP NIDDK, Bethesda, Maryland, United States, ou_persistent22              

Content

show
hide
Free keywords: Crystal cleavage, Inhibition, Ligands, Monomers, Peptides and proteins
 Abstract: The main protease Mpro, nsp5, of SARS-CoV-2 (SCoV2) is one of its most attractive drug targets. Here, we report primary screening data using nuclear magnetic resonance spectroscopy (NMR) of four different libraries and detailed follow-up synthesis on the promising uracil-containing fragment Z604 derived from these libraries. Z604 shows time-dependent binding. Its inhibitory effect is sensitive to reducing conditions. Starting with Z604, we synthesized and characterized 13 compounds designed by fragment growth strategies. Each compound was characterized by NMR and/or activity assays to investigate their interaction with Mpro. These investigations resulted in the four-armed compound 35b that binds directly to Mpro. 35b could be cocrystallized with Mpro revealing its noncovalent binding mode, which fills all four active site subpockets. Herein, we describe the NMR-derived fragment-to-hit pipeline and its application for the development of promising starting points for inhibitors of the main protease of SCoV2.

Details

show
hide
Language(s): eng - English
 Dates: 2023-11-302023-11-272023-12-012024-01-17
 Publication Status: Published online
 Pages: 12
 Publishing info: -
 Table of Contents: -
 Rev. Type: Peer
 Identifiers: DOI: 10.1021/acschembio.3c00720
BibTex Citekey: altincekic_targeting_2024
 Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show
hide
Title: ACS Chemical Biology
  Abbreviation : ACS Chem. Biol.
Source Genre: Journal
 Creator(s):
Affiliations:
Publ. Info: Washington, D.C. : American Chemical Society
Pages: - Volume / Issue: - Sequence Number: - Start / End Page: - Identifier: ISSN: 1554-8929
CoNE: https://pure.mpg.de/cone/journals/resource/1000000000035040